Morgan Stanley Reiterates Overweight on St. Jude Medical

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Morgan Stanley maintains St. Jude Medical (NYSE: STJ) at Overweight after inconclusive data from the Durata case. Morgan Stanley remarks, “Several unanswered questions surround the Durata case report today. The center and explanting physician need to be determined and the lead must be adjudicated. Before that, any determination is premature, in our view. Recall that several prior MAUDE reports of Durata externalized conductors driven by inside-out insulation breach were later determined to be erroneous. Fortunately, this process begins with physician identification and could occur in a matter of days.”STJ closed at $36.24 on Tuesday.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!